Table 1 Clinical characteristics of the study population.

From: Attenuation of cGVHD by C5a/C5aR blockade is associated with increased frequency of Treg

 

Health Controls

Non-GVHD

cGVHD

Male to female ratio

6:5

9:6

12:6

Age

30.18 ± 5.81

31.06 ± 8.89

29.44 ± 7.97

Primary disease before HSCT

NA

ALL:5

ALL:8

AML:8

AML:8

CML:1

CML:2

CMML:1

Donor

 Sibling

NA

8

8

 Matched unrelated

NA

7

10

  1. Abbreviations: ALL = acute lymphoblastic leukemia; AML = acute myeloid leukemia; CML = chronic myelogenous leukemia; CMML = Chronic myelomonocytic leukaemia; NA = not applicable.